APTN · OTC
Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.
Hover or tap a dot to see the filings behind that score.
Adaptin Bio, Inc. (the “Registrant”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”). The Registrant was unable to timely file its Form 10-K due to last minute processing delays, including certain adjustments to the text of the Form 10-K, which delays could not be eliminated by the Company without unreasonable effort and expense. The Registrant expects that the Form 10-K will be filed within the 15-calendar day extension period provided by Rule 12b-25
NT 10-K, filed 2026-04-01
Adaptin Bio, Inc. (the “Registrant”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”). The Registrant was unable to timely file its Form 10-K due to last minute processing delays, including certain adjustments to the text of the Form 10-K, which delays could not be eliminated by the Company without unreasonable effort and expense. The Registrant expects that the Form 10-K will be filed within the 15-calendar day extension period provided by Rule 12b-25
Adaptin Bio, Inc. (prior to the Merger, as defined below, “Unite Acquisition 1 Corp.”, or the “Registrant”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”). As previously disclosed in the Current Report on Form 8-K filed by the Registrant with the SEC on February 18, 2025, on February 11, 2025 (subsequent to the Registrant’s financial year-end), the Registrant entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) by and among the Registrant, Adaptin Acquisition Co. (“Merger Sub”), and Adaptin Bio, Inc. (“Private Adaptin”) pursuant to which, subject to the terms and conditions set forth in the Merger Agreement, Merger Sub merged with and into Private Adaptin (the “Merger”), with Private Adaptin surviving the Merger and becoming a wholly owned subsidiary of the Registrant. In connection with the Merger, the Registrant changed its name from “Unite Acquisition 1 Corp.” to “Adaptin Bio, Inc.” As a result of the Merger and corresponding adjustments necessary to the financial statements, the Registrant was unable to complete its audited financial statements for the twelve-month period ended December 31, 2024, and therefore unable to compile in a timely manner, without unreasonable effort or expense, the financial information required to prepare its Annual Report on Form 10-K for the year-ended December 31, 2024 (the “Form 10-K”), within the prescribed time period. The Registrant expects that the Form 10-K, along with the audited financial statements for the fiscal year ended December 31, 2024, will be filed within the 15-calendar day extension period provided by Rule 12b-25
2025-02-18auditor changed or resignednot counted — change of control SEC →
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice